Empirical Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.74M Buy
13,080
+1,258
+11% +$431K 0.07% 167
2026
Q1
$4.16M Sell
11,822
-423
-3% -$151K 0.07% 168
2025
Q4
$4.01M Buy
12,245
+252
+2% +$79.9K 0.07% 163
2025
Q3
$3.38M Buy
11,993
+490
+4% +$142K 0.07% 178
2025
Q2
$3.21M Sell
11,503
-154
-1% -$43.6K 0.07% 171
2025
Q1
$3.63M Sell
11,657
-1,657
-12% -$489K 0.09% 154
2024
Q4
$3.47M Buy
13,314
+329
+3% +$97.6K 0.09% 140
2024
Q3
$4.18M Sell
12,985
-2,492
-16% -$815K 0.12% 129
2024
Q2
$4.84M Buy
15,477
+7,979
+106% +$2.34M 0.14% 114
2024
Q1
$2.13M Buy
7,498
+1,860
+33% +$544K 0.06% 173
2023
Q4
$1.62M Buy
5,638
+637
+13% +$174K 0.05% 190
2023
Q3
$1.34M Buy
5,001
+123
+3% +$30.7K 0.05% 197
2023
Q2
$1.08M Sell
4,878
-945
-16% -$219K 0.04% 218
2023
Q1
$1.41M Buy
5,823
+300
+5% +$73.6K 0.06% 172
2022
Q4
$1.45M Hold
5,523
0.07% 165
2022
Q3
$1.25M Sell
5,523
-319
-5% -$77.3K 0.07% 175
2022
Q2
$1.42M Buy
5,842
+527
+10% +$129K 0.07% 168
2022
Q1
$1.28M Sell
5,315
-628
-11% -$144K 0.06% 181
2021
Q4
$1.34M Buy
5,943
+503
+9% +$106K 0.07% 170
2021
Q3
$1.16M Sell
5,440
-101
-2% -$23.2K 0.07% 169
2021
Q2
$1.35M Buy
5,541
+2,606
+89% +$641K 0.08% 149
2021
Q1
$730K Sell
2,935
-2,041
-41% -$487K 0.06% 197
2020
Q4
$1.14M Sell
4,976
-179
-3% -$41.3K 0.09% 139
2020
Q3
$1.31M Sell
5,155
-181
-3% -$44.8K 0.11% 121
2020
Q2
$1.26M Sell
5,336
-143
-3% -$32.6K 0.12% 113
2020
Q1
$1.11M Buy
5,479
+74
+1% +$16.2K 0.12% 108
2019
Q4
$1.3M Sell
5,405
-67
-1% -$14.8K 0.14% 102
2019
Q3
$1.06M Buy
5,472
+966
+21% +$185K 0.13% 112
2019
Q2
$830K Sell
4,506
-309
-6% -$55.3K 0.11% 112
2019
Q1
$915K Buy
4,815
+542
+13% +$104K 0.13% 96
2018
Q4
$832K Buy
4,273
+747
+21% +$146K 0.14% 85
2018
Q3
$731K Sell
3,526
-47
-1% -$9.26K 0.13% 91
2018
Q2
$660K Sell
3,573
-489
-12% -$86.5K 0.12% 91
2018
Q1
$692K Buy
4,062
+950
+31% +$174K 0.14% 82
2017
Q4
$541K Buy
3,112
+69
+2% +$12.2K 0.12% 87
2017
Q3
$567K Buy
3,043
+1
+0% +$177 0.13% 81
2017
Q2
$524K Hold
3,042
0.13% 81
2017
Q1
$499K Sell
3,042
-150
-5% -$24.9K 0.12% 85
2016
Q4
$467K Sell
3,192
-26
-0.8% -$3.91K 0.11% 79
2016
Q3
$537K Sell
3,218
-74
-2% -$12.5K 0.14% 67
2016
Q2
$501K Buy
3,292
+225
+7% +$35K 0.13% 66
2016
Q1
$460K Hold
3,067
0.11% 73
2015
Q4
$498K Hold
3,067
0.12% 71
2015
Q3
$424K Hold
3,067
0.1% 80
2015
Q2
$471K Hold
3,067
0.11% 76
2015
Q1
$490K Sell
3,067
-200
-6% -$31.5K 0.12% 66
2014
Q4
$520K Buy
3,267
+1
+0% +$156 0.13% 68
2014
Q3
$459K Hold
3,266
0.11% 70
2014
Q2
$387K Buy
3,266
+38
+1% +$4.4K 0.1% 74
2014
Q1
$398K Hold
3,228
0.1% 71
2013
Q4
$368K Buy
3,228
+1,200
+59% +$137K 0.1% 72
2013
Q3
$227K Buy
+2,028
New +$220K 0.07% 86

Other funds holding AMGN

Empirical Wealth Management's AMGN Position: Q2 2026 in Review

Empirical Wealth Management increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $431K and bringing the position to 13,080 shares worth $4.74M. The position accounts for 0.07% of the portfolio, ranked #167.

Empirical Wealth Management first reported a position in AMGN in Q3 2013 and has held it in 52 quarters since. The position peaked at $4.84M in Q2 2024. 1,292 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Empirical Wealth Management held 13,080 shares of Amgen worth $4.74M as of Q2 2026.
  • Empirical Wealth Management bought 1,258 Amgen shares in Q2 2026, an estimated $431K.
  • Amgen made up 0.07% of Empirical Wealth Management's portfolio in Q2 2026, its #167 holding.
  • Empirical Wealth Management first reported a position in Amgen in Q3 2013 and has held it in 52 quarters since.
  • Empirical Wealth Management's Amgen position peaked at $4.84M in Q2 2024.
  • 1,292 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.